APA (7th ed.) Citation

Ahmed, I. O., Asafa, M. A., Adeagbo, B. A., Adesunkanmi, O. O., Adedeji, T. A., Asaleye, C. M., . . . Durosinmi, M. A. (2025, January 13). Imatinib Induced Thyroid Dysfunction in BCR: :ABL1 Positive Chronic Myeloid Leukaemia Patients: Sokal Score as a Predictor. Indian journal of hematology & blood transfusion. https://doi.org/10.1007/s12288-024-01940-6

Chicago Style (17th ed.) Citation

Ahmed, Ibrahim Oluwaseun, Muritala Abiola Asafa, Babatunde Ayodeji Adeagbo, Omololu Olufunmilayo Adesunkanmi, Tewogbade Adeoye Adedeji, Christianah Mopelola Asaleye, Rahman Ayodele Bolarinwa, and Muheez Alani Durosinmi. "Imatinib Induced Thyroid Dysfunction in BCR: :ABL1 Positive Chronic Myeloid Leukaemia Patients: Sokal Score as a Predictor." Indian Journal of Hematology & Blood Transfusion 13 Jan. 2025. https://doi.org/10.1007/s12288-024-01940-6.

MLA (9th ed.) Citation

Ahmed, Ibrahim Oluwaseun, et al. "Imatinib Induced Thyroid Dysfunction in BCR: :ABL1 Positive Chronic Myeloid Leukaemia Patients: Sokal Score as a Predictor." Indian Journal of Hematology & Blood Transfusion, 13 Jan. 2025, https://doi.org/10.1007/s12288-024-01940-6.